Starpharma's anti-HIV and herpes microbicide is well tolerated by men, the company told the IAS conference today.

US scientists publish first bacterial genome transplantation, changing one species to another.

Everyone is excited about the use of RNAi in the laboratory, but some are now taking the next step and looking at its use in vivo.

Australian bitoech Apollo Life Sciences has released results of preliminary trials of a transdermally delivered tetanus vaccine.

Study also suggests link between late-onset Alzheimer's disease and irregular glucose levels.

Angiogenesis inhibition is not enough - blocking the formation of new lymphatic vessels is vital to preventing secondary tumours.

A lucky coincidence has led Australian plant researchers to two new genes responsible for salt tolerance in wheat.

Prana Biotechnology has raised $7.8 million in cash to add to its fund for a Phase IIa trial in human patients of its PBT2 compound for Alzheimer's disease.

People suffering from severe psoriasis may soon find symptom relief without injections, after a cream-based treatment being developed by Sydney biotechnology company Apollo Life Sciences outperformed current market-leading drugs in pre-clinical studies.

When the news of remarkable results in a pre-clinical trial of a potential drug for Alzheimer's disease was released in July, the headlines screamed and the share price for Prana Biotechnology went through the roof. Graeme O'Neill probes the details.

Animal health care company Vet Biotechnology has launched a collection service for equine umbilical cord stem cells from the afterbirth of newborn thoroughbred foals.